Skip to main content
Please enter a legal issue and/or a location
Begin typing to search, use arrow keys to navigate, use enter to select

Find a Lawyer

More Options

FDA Panel: Limit Anemia Drug Prescriptions

By Admin on March 14, 2008 | Last updated on March 21, 2019

Drugs used to treat anemia carry health risks and should only be prescribed to patients with certain types of incurable cancer, a panel of scientists has advised the U.S. Food and Drug Administration (FDA). The panel's findings apply to popular anemia medications like Aranesp and Procrit. These drugs, called erythropoiesis-stimulating agents (ESAs), are used in treatment of chemotherapy-associated anemia. According to the Los Angeles Times, Thursday's hearing on the safety and use of ESAs "focused on a growing theory that the drugs might in some instances do more harm than good." In February, a study published in the Journal of the American Medical Association article linked ESAs to an increased risk of death and blood clots in cancer patients.

You Don’t Have To Solve This on Your Own – Get a Lawyer’s Help

Meeting with a lawyer can help you understand your options and how to best protect your rights. Visit our attorney directory to find a lawyer near you who can help.

Or contact an attorney near you:
Copied to clipboard